News

Newsletter

28 de October de 2014

Newsletter 2014.07 – ANVISA publishes resolutions on new procedures relative to marketing authorization in Brazil: RDC #58 and #60/2014

The main law regulating the health system in Brazil – Law #6,360 dated 1976 – establishes that each and every drug available in the pharmaceutical market must be approved by the Ministry of Health. Since the creation of the Brazilian FDA (called ANVISA), this autonomous autarchy subordinated to the Ministry of Health is in charge of issuing marketing authorization for drugs for human use and of establishing specific resolutions in order to regulate each of the existing categories of medicaments, such as the new drugs, generics, similars, biologicals.

According to ANVISA’s requirements, the documentation submitted by the manufacturers of both generic and similar drugs, upon applying for marketing approval, is significantly simplified compared to the reference product (the so-called “abridged process”), as only pharmaceutical equivalence and relative bioavailability/ bioequivalence assays are required to obtain approval for products pertaining to these categories.

It should be noted that, since the publication of Resolutions RDC #133 (new applications for marketing approval) and RDC #134 (similars, already approved), both dated May 29, 2003, ANVISA has begun to require proof of therapeutic equivalence also for similar drugs; therefore, it is estimated that all manufacturers of these products will have complied with such requirement by the end of 2014.

Accordingly, studies of pharmaceutical equivalence and bioavailability/bioequivalence became necessary in order to obtain marketing authorization for both generic and similar drugs, although the latter were not then yet considered to be interchangeable with the reference product.

Back

Last related news

1 de July de 2025

New PPH Cycle Opens for Third Quarter of 2025 – Telecommunication Applications Excluded

In accordance with Ordinance 03/2025, published by the BPTO on March 25, 2025, a new limit of 800 Patent Prosecution Highway (PPH) New PPH Cycle Opens for Third Quarter of 2025 – Telecommunication Applications Excluded

Ler notícia

1 de July de 2025

Brazil’s Supreme Court Partially Strikes Down Internet Law Provision, Imposes Stricter Duty of Care on Online Platforms

On Thursday, June 26, the Brazilian Supreme Federal Court (STF) issued a landmark ruling, partially invalidating Article 19 of the Brazilian Internet Brazil’s Supreme Court Partially Strikes Down Internet Law Provision, Imposes Stricter Duty of Care on Online Platforms

Ler notícia

24 de June de 2025

Software License Compliance: A Constitutional and Strategic Right

In Brazil, the holder of intellectual property rights is entitled not only to economically exploit their work, but also to monitor how Software License Compliance: A Constitutional and Strategic Right

  • Kasznar Leonardos
  • Ler notícia
    plugins premium WordPress